|
⚲
|
| Keyboard |
| Dylan-Hyde Tyler
✚
|
|
|---|---|
| CIK # | 0001682027 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001682027] | |
| 4 | [0001682027] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Dylan-Hyde Tyler | |
| CRISPR Therapeutics AG |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2018-01-16 | Sell | 1,110 | $28.24 | 31,346 |
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2018-01-16 | Option exercise | 1,110 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2018-01-16 | Option exercise | 19,890 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2018-01-16 | Sell | 19,890 | $28.10 | 558,909 |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2018-01-16 | Sell | 45,000 | $28.00 | 1,260,000 |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2018-01-16 | Option exercise | 1,110 | $12.57 | 13,953 |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2018-01-16 | Option exercise | 19,890 | $12.57 | 250,017 |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2018-01-02 | Sell | 30,000 | $20.55 | 616,500 |
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2018-01-02 | Option exercise | 6,490 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2018-01-02 | Option exercise | 1,510 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2018-01-02 | Option exercise | 8,000 | $12.57 | 100,560 |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2018-01-02 | Sell | 8,000 | $25.75 | 206,000 |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2017-12-29 | Sell | 6,230 | $21.75 | 135,502 |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2017-12-29 | Sell | 8,000 | $23.76 | 190,080 |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2017-12-29 | Option exercise | 6,230 | $14.43 | 89,899 |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2017-12-29 | Option exercise | 9,070 | $12.57 | 114,010 |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2017-12-29 | Sell | 1,070 | $21.75 | 23,272 |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2017-12-29 | Sell | 15,000 | $22.68 | 340,200 |
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2017-12-29 | Option exercise | 6,230 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2017-12-29 | Option exercise | 9,070 | $0.00 | |
| showing 20 of 39 most recent transactions | |||||